| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
PCRX
Pacira Pharmaceuticals
|
Jul 01, 2026 | BUY |
Buy
+53.3% avg upside
21 analysts
|
$38.00
49.59% Upside
|
+1.4% |
|
SE:HNSA
Hansa Biopharma AB
|
Jun 29, 2026 | BUY |
Strong Buy
+302.8% avg upside
4 analysts
|
$103.00
195.35% Upside
|
· |
|
VRDN
Viridian Therapeutics
|
Jun 29, 2026 | BUY |
Strong Buy
+81.3% avg upside
32 analysts
|
$22.00
13.33% Upside
|
+1.2% |
|
ARGX
Argenx Se
|
Jun 25, 2026 | BUY |
Strong Buy
-20.2% avg upside
46 analysts
|
$940.00
0.00% Downside
|
+5.7% |
|
ALKS
Alkermes
|
Jun 18, 2026 | HOLD |
Strong Buy
-29.0% avg upside
34 analysts
|
$43.00
21.15% Downside
|
+15.0% |
|
NMRA
Neumora Therapeutics, Inc.
|
Jun 16, 2026 | BUY |
Buy
+372.4% avg upside
11 analysts
|
$7.00
319.23% Upside
|
+10.3% |
|
CRNX
Crinetics Pharmaceuticals
|
Jun 15, 2026 | BUY |
Strong Buy
+86.3% avg upside
21 analysts
|
$81.00
91.84% Upside
|
· |
|
RZLT
Rezolute
|
Jun 15, 2026 | BUY |
Strong Buy
+116.7% avg upside
13 analysts
|
$5.00
1.88% Upside
|
· |
|
CABA
Cabaletta Bio
|
Jun 08, 2026 | BUY |
Strong Buy
+336.2% avg upside
16 analysts
|
— | · |
|
PRAX
Praxis Precision Medicines
|
Jun 08, 2026 | BUY |
Strong Buy
+66.4% avg upside
24 analysts
|
$1201.00
277.11% Upside
|
+23.8% |
|
IRON
Disc Medicine
|
Jun 08, 2026 | BUY |
Strong Buy
+11.6% avg upside
21 analysts
|
— | +15.9% |
|
BHVN
Biohaven Ltd.
|
Jun 01, 2026 | HOLD |
Buy
+43.4% avg upside
25 analysts
|
$10.00
37.28% Downside
|
+40.4% |
|
IMVT
Immunovant
|
May 26, 2026 | BUY |
Strong Buy
-0.4% avg upside
24 analysts
|
$40.00
3.20% Upside
|
+14.1% |
|
ROIV
Roivant Sciences
|
May 21, 2026 | BUY |
Strong Buy
-8.3% avg upside
17 analysts
|
$34.00
3.24% Downside
|
+13.8% |
|
DARE
Daré Bioscience
|
May 15, 2026 | BUY |
Strong Buy
+540.4% avg upside
14 analysts
|
$12.00
474.22% Upside
|
· |
|
CHRS
Coherus Biosciences
|
May 12, 2026 | BUY |
Buy
+765.9% avg upside
18 analysts
|
$7.00
382.82% Upside
|
-13.4% |
|
PTGX
Protagonist Therapeutics
|
May 11, 2026 | BUY |
Strong Buy
-33.1% avg upside
19 analysts
|
$117.00
11.06% Downside
|
+27.1% |
|
ARQT
Arcutis Biotherapeutics
|
May 11, 2026 | BUY |
Strong Buy
+51.9% avg upside
14 analysts
|
$34.00
31.75% Upside
|
+21.5% |
|
NERV
Minerva Neurosciences
|
May 11, 2026 | HOLD |
Buy
+47.0% avg upside
8 analysts
|
$7.00
37.21% Upside
|
-12.6% |
|
XENE
Xenon
|
May 08, 2026 | BUY |
Strong Buy
+3.3% avg upside
28 analysts
|
$74.00
21.38% Upside
|
+8.0% |
|
EOLS
Evolus
|
May 05, 2026 | BUY |
Strong Buy
+107.7% avg upside
9 analysts
|
$13.00
88.37% Upside
|
+5.8% |
|
OTLK
Outlook Therapeutics
|
Apr 08, 2026 | HOLD |
Buy
+509.3% avg upside
11 analysts
|
$0.50
65.50% Downside
|
+532.0% |
|
RAPP
Rapport Therapeutics, Inc.
|
Mar 11, 2026 | BUY |
Strong Buy
+39.3% avg upside
13 analysts
|
$40.00
2.64% Upside
|
+26.3% |
|
TBPH
Theravance Biopharma
|
Mar 04, 2026 | BUY |
Buy
+8.2% avg upside
18 analysts
|
$15.00
11.41% Downside
|
+29.0% |
|
EVO
Evotec AG
|
Nov 06, 2025 | BUY |
Strong Buy
+242.2% avg upside
9 analysts
|
$7.00
141.45% Upside
|
-13.3% |
|
TRVN
Trevena
|
Nov 14, 2024 | HOLD |
Buy
+949900.0% avg upside
11 analysts
|
$5.00
333233.38% Upside
|
· |
|
AEON
AEON Biopharma
|
Oct 01, 2024 | BUY |
Strong Buy
+50242.6% avg upside
1 analyst
|
$360.00
50242.58% Upside
|
-98.9% |
|
RVLPQ
RVL Pharmaceuticals
|
Aug 21, 2023 | BUY |
Strong Buy
+624999900.0% avg upside
6 analysts
|
$3.00
299999900.08% Upside
|
-99.9% |
|
ADOCY
Adocia
|
Apr 21, 2023 | HOLD |
Hold
1 analyst
|
— | · |
|
CLYM
Climb Bio
|
Mar 08, 2023 | HOLD |
Strong Buy
+40.1% avg upside
18 analysts
|
$6.00
53.57% Downside
|
-25.0% |
|
TXMD
TherapeuticsMD
|
Nov 30, 2022 | HOLD |
Buy
+196.2% avg upside
8 analysts
|
— | -43.7% |
|
TEVA
Teva Pharmaceutical
|
Aug 06, 2018 | HOLD |
Buy
-15.2% avg upside
39 analysts
|
$23.00
33.57% Downside
|
-68.1% |
|
PAHC
Phibro Animal Health
|
Jul 03, 2018 | SELL |
Hold
+12.0% avg upside
10 analysts
|
$33.00
0.74% Downside
|
+30.5% |
|
TSE:BHC
Bausch Health Companies
|
Jun 06, 2018 | BUY |
Buy
+761.4% avg upside
29 analysts
|
— | · |
|
PRGO
Perrigo Company
|
Jun 06, 2018 | HOLD |
Buy
+519.0% avg upside
20 analysts
|
$80.00
625.93% Upside
|
-39.8% |
|
AMRX
Amneal Pharmaceuticals
|
May 01, 2018 | BUY |
Strong Buy
+0.3% avg upside
18 analysts
|
$27.00
57.35% Upside
|
-15.6% |
|
ZTS
Zoetis
|
Feb 16, 2018 | HOLD |
Buy
+72.6% avg upside
22 analysts
|
$77.00
2.87% Upside
|
+20.4% |
|
ICLR
Icon
|
Oct 27, 2017 | HOLD |
Strong Buy
+8.1% avg upside
25 analysts
|
$120.00
30.62% Downside
|
+14.3% |
|
IQV
IQVIA Holdings
|
Oct 27, 2017 | BUY |
Strong Buy
+8.9% avg upside
38 analysts
|
$120.00
41.98% Downside
|
+11.6% |
|
HALO
Halozyme
|
Jun 22, 2017 | BUY |
Strong Buy
-25.5% avg upside
20 analysts
|
$16.00
79.77% Downside
|
+22.0% |
|
VTRS
Viatris
|
May 22, 2017 | BUY |
Buy
+36.6% avg upside
21 analysts
|
$50.00
199.38% Upside
|
+1.5% |
|
JAZZ
Jazz Pharmaceuticals
|
Jan 18, 2017 | BUY |
Strong Buy
-9.4% avg upside
35 analysts
|
$200.00
17.76% Downside
|
+16.1% |
|
CRL
Charles River Labs
|
Nov 30, 2016 | HOLD |
Strong Buy
-10.3% avg upside
34 analysts
|
— | +46.6% |
|
ARCT
Arcturus Therapeutics
|
Nov 16, 2016 | SELL |
Buy
+303.6% avg upside
36 analysts
|
$2.00
72.57% Downside
|
+25.9% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.